These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7529760)

  • 1. Regulation of Src family kinases in the developing rat brain: correlation with their regulator kinase, Csk.
    Inomata M; Takayama Y; Kiyama H; Nada S; Okada M; Nakagawa H
    J Biochem; 1994 Aug; 116(2):386-92. PubMed ID: 7529760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification of bovine thymus cytosolic C-terminal Src kinase (CSK) and demonstration of differential efficiencies of phosphorylation and inactivation of p56lyn and pp60c-src by CSK.
    Cheng HC; Bjorge JD; Aebersold R; Fujita DJ; Wang JH
    Biochemistry; 1996 Sep; 35(36):11874-87. PubMed ID: 8794770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid and efficient purification of Src homology 2 domain-containing proteins: Fyn, Csk and phosphatidylinositol 3-kinase p85.
    Koegl M; Kypta RM; Bergman M; Alitalo K; Courtneidge SA
    Biochem J; 1994 Sep; 302 ( Pt 3)(Pt 3):737-44. PubMed ID: 7524477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CSK: a protein-tyrosine kinase involved in regulation of src family kinases.
    Okada M; Nada S; Yamanashi Y; Yamamoto T; Nakagawa H
    J Biol Chem; 1991 Dec; 266(36):24249-52. PubMed ID: 1722201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of C-terminal src kinase in human colorectal cancer cell lines.
    Watanabe N; Matsuda S; Kuramochi S; Tsuzuku J; Yamamoto T; Endo K
    Jpn J Clin Oncol; 1995 Feb; 25(1):5-9. PubMed ID: 7533218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of c-Fgr protein kinase by c-Src kinase (CSK) and by polycationic effectors.
    Ruzzene M; James P; Brunati AM; Donella-Deana A; Pinna LA
    J Biol Chem; 1994 Jun; 269(22):15885-91. PubMed ID: 7515063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced C-terminal Src kinase (Csk) activities in hepatocellular carcinoma.
    Masaki T; Okada M; Tokuda M; Shiratori Y; Hatase O; Shirai M; Nishioka M; Omata M
    Hepatology; 1999 Feb; 29(2):379-84. PubMed ID: 9918913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced C-terminal Src kinase activity is correlated inversely with pp60(c-src) activity in colorectal carcinoma.
    Cam WR; Masaki T; Shiratori Y; Kato N; Ikenoue T; Okamoto M; Igarashi K; Sano T; Omata M
    Cancer; 2001 Jul; 92(1):61-70. PubMed ID: 11443610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific and redundant roles of Src and Fyn in organizing the cytoskeleton.
    Thomas SM; Soriano P; Imamoto A
    Nature; 1995 Jul; 376(6537):267-71. PubMed ID: 7617039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spleen protein tyrosine kinases TPK-IIB and CSK display different immunoreactivity and opposite specificities toward c-src-derived peptides.
    Brunati AM; Allee G; Marin O; Donella-Deana A; Cesaro L; Bougeret C; Fagard R; Benarous R; Fischer S; Pinna LA
    FEBS Lett; 1992 Nov; 313(3):291-4. PubMed ID: 1280230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the binding of the Src homology 2 domain of Csk to tyrosine-phosphorylated proteins in the suppression and mitotic activation of c-Src.
    Sabe H; Hata A; Okada M; Nakagawa H; Hanafusa H
    Proc Natl Acad Sci U S A; 1994 Apr; 91(9):3984-8. PubMed ID: 7513429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Csk-binding protein (Cbp) negatively regulates epidermal growth factor-induced cell transformation by controlling Src activation.
    Jiang LQ; Feng X; Zhou W; Knyazev PG; Ullrich A; Chen Z
    Oncogene; 2006 Sep; 25(40):5495-506. PubMed ID: 16636672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ctk: a protein-tyrosine kinase related to Csk that defines an enzyme family.
    Klages S; Adam D; Class K; Fargnoli J; Bolen JB; Penhallow RC
    Proc Natl Acad Sci U S A; 1994 Mar; 91(7):2597-601. PubMed ID: 7511815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of c-Src activity by C-terminal Src kinase involves the c-Src SH2 and SH3 domains: analysis with Saccharomyces cerevisiae.
    Murphy SM; Bergman M; Morgan DO
    Mol Cell Biol; 1993 Sep; 13(9):5290-300. PubMed ID: 7689149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The p60c-src family of protein-tyrosine kinases: structure, regulation, and function.
    Brickell PM
    Crit Rev Oncog; 1992; 3(4):401-46. PubMed ID: 1384720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of major tyrosine-phosphorylated proteins in Csk-deficient cells.
    Nada S; Okada M; Aizawa S; Nakagawa H
    Oncogene; 1994 Dec; 9(12):3571-8. PubMed ID: 7526315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylation of Src mutants at Tyr 527 in fibroblasts does not correlate with in vitro phosphorylation by CSK.
    MacAuley A; Okada M; Nada S; Nakagawa H; Cooper JA
    Oncogene; 1993 Jan; 8(1):117-24. PubMed ID: 7678701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of Csk homologous kinase (CHK) in normal brain and brain tumors.
    Kim SO; Avraham S; Jiang S; Zagozdzon R; Fu Y; Avraham HK
    Cancer; 2004 Sep; 101(5):1018-27. PubMed ID: 15329911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ubiquitin-dependent degradation of active Src.
    Hakak Y; Martin GS
    Curr Biol; 1999 Sep; 9(18):1039-42. PubMed ID: 10508617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural requirements for the efficient regulation of the Src protein tyrosine kinase by Csk.
    Koegl M; Courtneidge SA; Superti-Furga G
    Oncogene; 1995 Dec; 11(11):2317-29. PubMed ID: 8570183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.